Works matching IS 15268209 AND DT 2012 AND VI 12 AND IP 4


Results: 13
    1
    2
    4

    Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials.

    Published in:
    2012
    By:
    • Valero V;
    • Vrdoljak E;
    • Xu B;
    • Thomas E;
    • Gómez H;
    • Manikhas A;
    • Medina C;
    • Li RK;
    • Ro J;
    • Bosserman L;
    • Vahdat L;
    • Mukhopadhyay P;
    • Opatt D;
    • Sparano JA;
    • Valero, Vicente;
    • Vrdoljak, Eduard;
    • Xu, Binghe;
    • Thomas, Eva;
    • Gómez, Henry;
    • Manikhas, Alexey
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10
    11

    Primary neuroendocrine breast carcinoma.

    Published in:
    2012
    By:
    • Menéndez P;
    • García E;
    • Rabadán L;
    • Pardo R;
    • Padilla D;
    • Villarejo P;
    • Menéndez, Pablo;
    • García, Esther;
    • Rabadán, Lorenzo;
    • Pardo, Ricardo;
    • Padilla, David;
    • Villarejo, Pedro
    Publication type:
    journal article
    12